xeljanz-vs-stelara

xeljanz-vs-stelara

xeljanz vs stelara

STELARA is a tradition drug approved to treat grown-ups and children 6 times and aged with active psoriatic arthritis. FDA- approved to help control the four crucial signs of PsA, STELARA needs to be administered four times a time (after two starter boluses) — lower than any other PsA treatment of its kind. Ask your croaker or rheumatologist how STELARA can help.

Xeljanz (tofacitinib citrate), on the other hand, is a Janus kinase (JAK) inhibitor that is used to treat adults with moderate to severe active rheumatoid arthritis (RA) who have not responded to or cannot tolerate methotrexate.

Xeljanz (tofacitinib citrate) is a Janus kinase (JAK) inhibitor used to treat rheumatoid arthritis.. Xeljanz is an oral medication that works differently from the injectable medications and Enbrel to lessen joint pain and swelling caused by rheumatoid arthritis.

. Long-term safety studies have shown that Xeljanz may raise your risk of developing serious heart problems and cancer more than Enbrel.